(Q34383304)

English

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). (English)

1 reference

Europe PubMed Central

1 August 2017

0 references

0 references

circulatory system

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Alain Cohen-Solal

7

object named as

Alain Cohen-Solal

1 reference

Europe PubMed Central

1 August 2017

12

object named as

Luigi Tavazzi

1 reference

Europe PubMed Central

1 August 2017

Stefan D. Anker

16

object named as

Stefan D Anker

1 reference

Europe PubMed Central

1 August 2017

Dirk J. Van Veldhuisen

4

object named as

Dirk J Van Veldhuisen

1 reference

Europe PubMed Central

1 August 2017

Philip Poole-Wilson

18

object named as

Philip A Poole-Wilson

1 reference

Europe PubMed Central

1 August 2017

author name string

Marcus D Flather

1

1 reference

Europe PubMed Central

1 August 2017

Marcelo C Shibata

2

1 reference

Europe PubMed Central

1 August 2017

Andrew J S Coats

3

1 reference

Europe PubMed Central

1 August 2017

Aleksandr Parkhomenko

5

1 reference

Europe PubMed Central

1 August 2017

Joszef Borbola

6

1 reference

Europe PubMed Central

1 August 2017

Dan Dumitrascu

8

1 reference

Europe PubMed Central

1 August 2017

Roberto Ferrari

9

1 reference

Europe PubMed Central

1 August 2017

Philippe Lechat

10

1 reference

Europe PubMed Central

1 August 2017

Jordi Soler-Soler

11

1 reference

Europe PubMed Central

1 August 2017

Lenka Spinarova

13

1 reference

Europe PubMed Central

1 August 2017

Jiri Toman

14

1 reference

Europe PubMed Central

1 August 2017

Michael Böhm

15

1 reference

Europe PubMed Central

1 August 2017

Simon G Thompson

17

1 reference

Europe PubMed Central

1 August 2017

SENIORS Investigators

19

1 reference

Europe PubMed Central

1 August 2017

publication date

9 January 2005

1 reference

Europe PubMed Central

1 August 2017

European Heart Journal

1 reference

Europe PubMed Central

1 August 2017

26

1 reference

Europe PubMed Central

1 August 2017

215-225

1 reference

Europe PubMed Central

1 August 2017

3

1 reference

Europe PubMed Central

1 August 2017

The epidemiology of heart failure: the Framingham Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI115

21 January 2018

The epidemiology of heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI115

21 January 2018

Hospitalization of patients with heart failure: a population-based study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI115

21 January 2018

The current cost of heart failure to the National Health Service in the UK.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI115

21 January 2018

Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI115

21 January 2018

Course and prognosis in patients > or = 70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI115

21 January 2018

Expert consensus document on beta-adrenergic receptor blockers

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI115

21 January 2018

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI115

21 January 2018

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI115

21 January 2018

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI115

21 January 2018

Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI115

21 January 2018

Pharmacological mechanisms of clinically favorable properties of a selective beta1-adrenoceptor antagonist, nebivolol

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI115

21 January 2018

Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI115

21 January 2018

Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS). Rationale and design

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI115

21 January 2018

Efficacy, safety and tolerability of beta-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI115

21 January 2018

Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI115

21 January 2018

Beta blockers in older persons with heart failure: tolerability and impact on quality of life

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI115

21 January 2018

Rate of heart failure and 1-year survival for older people receiving low-dose beta-blocker therapy after myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI115

21 January 2018

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI115

21 January 2018

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI115

21 January 2018

Baseline predictors of tolerability to carvedilol in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI115

21 January 2018

Obstacles to the initiation of beta blockers for heart failure in a specialised clinic within a district general hospital

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI115

21 January 2018

Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI115

21 January 2018

Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of two worlds—the TEMISTOCLE study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI115

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHI115

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34383304&oldid=2116347818"